ATE296791T1 - Verfahren zur herstellung von direkt tablettierbarem alpha-mannit - Google Patents

Verfahren zur herstellung von direkt tablettierbarem alpha-mannit

Info

Publication number
ATE296791T1
ATE296791T1 AT02795184T AT02795184T ATE296791T1 AT E296791 T1 ATE296791 T1 AT E296791T1 AT 02795184 T AT02795184 T AT 02795184T AT 02795184 T AT02795184 T AT 02795184T AT E296791 T1 ATE296791 T1 AT E296791T1
Authority
AT
Austria
Prior art keywords
mannitol
alpha
producing directly
directly tabletable
beta
Prior art date
Application number
AT02795184T
Other languages
German (de)
English (en)
Inventor
Martin Erdmann
Walter Hamm
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7709161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE296791(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE296791T1 publication Critical patent/ATE296791T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Glanulating (AREA)
AT02795184T 2001-12-13 2002-12-13 Verfahren zur herstellung von direkt tablettierbarem alpha-mannit ATE296791T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10161402A DE10161402A1 (de) 2001-12-13 2001-12-13 Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
PCT/EP2002/014202 WO2003055834A2 (de) 2001-12-13 2002-12-13 VERFAHREN ZUR HERSTELLUNG VON DIREKT TABLETTIERBAREM α-MANNIT

Publications (1)

Publication Number Publication Date
ATE296791T1 true ATE296791T1 (de) 2005-06-15

Family

ID=7709161

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02795184T ATE296791T1 (de) 2001-12-13 2002-12-13 Verfahren zur herstellung von direkt tablettierbarem alpha-mannit

Country Status (7)

Country Link
US (2) US6998481B2 (https=)
EP (2) EP1319644B2 (https=)
JP (3) JP5537755B2 (https=)
AT (1) ATE296791T1 (https=)
AU (2) AU2002360958A1 (https=)
DE (3) DE10161402A1 (https=)
WO (2) WO2003053896A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10161402A1 (de) † 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE10240778A1 (de) * 2002-08-30 2004-03-11 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem a-Mannit
US8186265B2 (en) * 2005-08-08 2012-05-29 Ron's Enterprises, Inc. Device to efficiently cook food
US20090208576A1 (en) * 2006-03-31 2009-08-20 Gandhi Anilkumar S Orally Disintegrating Tablets
US20100092564A1 (en) * 2006-12-21 2010-04-15 Jae Han Park Composition of and Method for Preparing Orally Disintegrating Tablets
CN103691530A (zh) * 2007-07-27 2014-04-02 卡吉尔公司 多元醇的微粉化
TR201808694T4 (tr) 2008-06-20 2018-07-23 Merck Patent Gmbh Doğrudan sıkıştırılabilen ve hızlı parçalanan tablet matrisi.
FR2933299B1 (fr) * 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
WO2010021300A1 (ja) 2008-08-18 2010-02-25 三菱商事フードテック株式会社 新規マンニトール打錠用賦形剤
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
JP6038651B2 (ja) 2009-07-10 2016-12-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 錠剤を製造するための組成物の調製方法
EP2451447B1 (de) 2009-07-10 2017-10-11 Merck Patent GmbH Wasserarmes tablettierhilfsmittel und verfahren zu seiner herstellung
CA2776570A1 (en) 2009-10-12 2011-04-21 Basf Se Process for the preparation of a powder comprising one or more complexing agent salts
PL3093011T3 (pl) * 2010-12-17 2021-09-06 Merck Patent Gmbh Sposób otrzymywania bezpośrednio tabletkowalnego delta-mannitolu
AR086505A1 (es) 2012-05-21 2013-12-18 Consejo Nac Invest Cient Tec Un excipiente co-procesado, obtenido mediante secado por atomizacion, utilizable como excipiente farmaceutico o aditivo alimenticio
WO2015046489A1 (ja) * 2013-09-30 2015-04-02 第一三共株式会社 スプレードライ法を用いたＤ－マンニトールα型結晶の選択的製造方法
FR3038836B1 (fr) 2015-07-17 2017-07-14 Roquette Freres Granules de mannitol pour compression directe
CN110172012A (zh) * 2019-07-06 2019-08-27 浙江华康药业股份有限公司 直接压片甘露醇的制备方法
CN110787722A (zh) * 2019-12-01 2020-02-14 浙江华康药业股份有限公司 一种结晶甘露醇干法造粒装置及工艺
AU2023217824A1 (en) 2022-02-08 2024-08-01 Roquette Freres Directly compressible mannitol granules
FR3132522B1 (fr) 2022-02-08 2025-04-04 Roquette Freres Granules de mannitol directement comprimable
CN115671053A (zh) * 2022-11-09 2023-02-03 江西中医药大学 一种含有多孔甘露醇的载药粉末的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) * 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
FR2571045B1 (fr) * 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
FR2571046B1 (fr) * 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
JPS6185330A (ja) * 1984-10-04 1986-04-30 Fuji Kagaku Kogyo Kk 直打用賦形薬の製造法
DK160809C (da) * 1989-01-09 1995-10-02 Niro Holding As Fremgangsmåde og forstøvningstørringsapparat til fremstilling af stabile partikelagglomerater
ATE128959T1 (de) * 1989-01-24 1995-10-15 Spi Polyols Inc Kryoschützende kristalline sorbitolkügelchen.
FR2710637B1 (fr) * 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
JP3126683B2 (ja) * 1996-04-16 2001-01-22 武田薬品工業株式会社 Ｄ−マンニトールおよびその製造法
PL329614A1 (en) * 1996-04-16 1999-03-29 Bayer Ag D-mannitoll and method of obtaining same
DE19615418A1 (de) † 1996-04-22 1997-10-23 Merck Patent Gmbh Polyol-Zusammensetzung
DE19927537A1 (de) † 1999-06-16 2000-12-21 Merck Patent Gmbh Sprühtrocknungsanlage und Verfahren zu ihrer Verwendung
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit

Also Published As

Publication number Publication date
JP2013139455A (ja) 2013-07-18
WO2003053896A1 (de) 2003-07-03
DE50205571D1 (de) 2006-04-06
EP1453781B1 (de) 2005-06-01
JP2004002290A (ja) 2004-01-08
US6998482B2 (en) 2006-02-14
WO2003055834A2 (de) 2003-07-10
JP2005513151A (ja) 2005-05-12
US20030114717A1 (en) 2003-06-19
JP5537755B2 (ja) 2014-07-02
DE50203302D1 (de) 2005-07-07
WO2003055834A3 (de) 2003-10-16
US20050008693A1 (en) 2005-01-13
AU2002360972A1 (en) 2003-07-15
US6998481B2 (en) 2006-02-14
EP1319644A1 (de) 2003-06-18
DE10161402A1 (de) 2003-06-18
EP1319644B2 (de) 2009-04-01
EP1453781A2 (de) 2004-09-08
EP1453781B2 (de) 2014-03-05
AU2002360958A1 (en) 2003-07-09
EP1319644B1 (de) 2006-01-11

Similar Documents

Publication Publication Date Title
ATE296791T1 (de) Verfahren zur herstellung von direkt tablettierbarem alpha-mannit
ATE297196T1 (de) Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
DE69921941D1 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
ATE294137T1 (de) Verfahren zur herstellung von orthokieselsäure, sowie nach dem verfahren hergestellte kieselsäure und ihre verwendung
DE69938201D1 (de) Mikropartikel
ATE401313T1 (de) Herstellung von risperidon
ATE380016T1 (de) Aufstreuverfahren zur herstellung von pulverformulierungen
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
ATE238323T1 (de) Pulverisierte-sorbitol und ihr verfahren zur herstellung
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
ATE159512T1 (de) Prozess zur herstellung von beta-phenylisoserin und analogen verbindungen
PL336640A1 (en) Substituted 3,3-diamino-2- propenonitriles, their production and application
WO2003053136A3 (en) Triple transgenic mouse model of alzheimer's disease
EP1069122A4 (en) PROCESS FOR PRODUCING 5-HYDROXYBENZO b] THIOPHENE-3-CARBOXYLIC ACID DERIVATIVES
DE60209499D1 (de) Verfahren zur herstellung von nylon 6,6
ATE181507T1 (de) Harpagosid-angereicherter extrakt aus harpagophytum procumbens und verfahren zu seiner herstellung
WO2001068676A3 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
DE60033414D1 (de) Allergievakzine sowie ihre Herstellung
DE50209196D1 (de) Verfahren zur herstellung von bleichaktivatorgranulaten
ATE342254T1 (de) Verfahren zur herstellung von derivaten von [(1,5-diaryl)pyrazol-3-ylöpropansäure
DE50104847D1 (de) Verfahren zur herstellung chiraler verbindungen
ATE288901T1 (de) Verfahren zur herstellung von 5-hydroxymethyl-2- oxazolidinon und neues zwischenprodukt
ATE250581T1 (de) Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee